Wall Street Zen Upgrades Danaher (NYSE:DHR) to Buy

Key Points

• Wall Street Zen upgraded Danaher to “Buy” from “Hold,” adding to an overall “Moderate Buy” consensus supported by 18 Buy, one Strong Buy and four Hold ratings.
• Analysts largely raised their price targets, with TD Cowen and JPMorgan setting targets of $270; the consensus target is $242.91 versus shares opening at $230.36.
• Danaher reported quarterly EPS of $2.11, beating the $1.92 estimate, while revenue rose 8.3% year over year to $6.55 billion. However, tariff pressure, execution concerns and a cautious 2027 outlook remain risks despite higher 2026 guidance.

Danaher (NYSE:DHR - Get Free Report) was upgraded by research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued to clients and investors on Monday, Wall Street Zen reports.

A number of other equities analysts also recently weighed in on the stock. Wells Fargo & Company dropped their target price on shares of Danaher from $212.00 to $195.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 22nd. TD Cowen increased their price target on shares of Danaher from $255.00 to $270.00 and gave the company a "buy" rating in a research note on Thursday. Barclays raised their price target on shares of Danaher from $255.00 to $260.00 and gave the company an "overweight" rating in a report on Thursday. Stifel Nicolaus boosted their price objective on shares of Danaher from $220.00 to $260.00 and gave the stock a "buy" rating in a research report on Thursday. Finally, JPMorgan Chase & Co. upped their price objective on Danaher from $250.00 to $270.00 and gave the stock an "overweight" rating in a report on Thursday. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $242.91.

Danaher Stock Down 0.1%

Shares of DHR opened at $230.36 on Monday. Danaher has a 52 week low of $160.93 and a 52 week high of $242.80. The firm has a market capitalization of $162.07 billion, a P/E ratio of 37.70, a P/E/G ratio of 2.89 and a beta of 0.76. The company has a 50-day simple moving average of $216.32 and a 200-day simple moving average of $197.39. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The business had revenue of $6.55 billion during the quarter, compared to analysts' expectations of $6.56 billion. During the same period in the prior year, the firm posted $1.89 EPS. Danaher's quarterly revenue was up 8.3% compared to the same quarter last year. On average, equities research analysts expect that Danaher will post 8.59 earnings per share for the current year.

Institutional Investors Weigh In On Danaher

Several hedge funds have recently bought and sold shares of the company. Gunderson Capital Management LLC acquired a new position in shares of Danaher during the third quarter worth about $765,000. EP Wealth Advisors LLC acquired a new position in Danaher during the second quarter worth $3,807,000. Frank Rimerman Advisors LLC raised its holdings in shares of Danaher by 181.9% in the 3rd quarter. Frank Rimerman Advisors LLC now owns 40,855 shares of the conglomerate's stock valued at $9,051,000 after purchasing an additional 26,363 shares during the period. Birch Hill Investment Advisors LLC raised its stake in Danaher by 9.6% in the third quarter. Birch Hill Investment Advisors LLC now owns 40,549 shares of the conglomerate's stock valued at $8,984,000 after buying an additional 3,553 shares during the period. Finally, Forbes J M & Co. LLP raised its stake in Danaher by 141.6% in the third quarter. Forbes J M & Co. LLP now owns 4,276 shares of the conglomerate's stock valued at $947,000 after buying an additional 2,506 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher News Roundup

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher reported third-quarter adjusted earnings of $2.11 per share, above the $1.92 analyst consensus, while revenue reached approximately $6.55 billion. Revenue increased 8.3% year over year, and management raised its full-year 2026 adjusted EPS outlook. Danaher 3Q Net Up Sharply as Company Boosts 2026 Adjusted EPS View
• Positive Sentiment: Analysts raised their valuation targets following the results. TD Cowen and JPMorgan lifted targets to $270, Goldman Sachs raised its target to $275, Stifel increased its target to $260, and Robert W. Baird raised its target to $254. The firms maintained bullish ratings, including Buy, Overweight and Outperform. Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
• Positive Sentiment: Management highlighted margin strength, improved execution and an increased focus on innovation and artificial intelligence, factors analysts viewed as supporting a better longer-term outlook. Danaher Earnings Call Highlights Margin Strength, AI Push
• Neutral Sentiment: Despite the earnings beat and higher targets, shares declined in the immediate post-results reaction, suggesting investors may have already priced in much of the improvement. A recent valuation comparison also frames DHR as a stock for investors weighing quality and growth against its relatively elevated valuation. Danaher Q3 Recap: Decent Results, Still A Hold
• Negative Sentiment: Danaher’s new CEO emphasized the need for better execution and innovation. TD Cowen cited tariff pressure and a cautious 2027 outlook, creating uncertainty beyond the raised 2026 guidance and helping explain why the stock did not fully respond to the strong quarterly report. Danaher Posts First Earnings Under New CEO

Danaher Company Profile

Danaher Corporation NYSE: DHR is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.